Promise of Cost-effective Healthcare Delivery to Boost Remote Patient Monitoring Market, Says Frost & Sullivan

Benefits include customised care in home-settings and reduced public healthcare expenditure

Apr 18, 2013, 04:00 ET from Frost & Sullivan

LONDON, April 18, 2013 /PRNewswire/ -- Remote patient monitoring (RPM) technologies help patients retain their independence and avert further health complications. These technologies can also be a vital tool for governments to curb spiralling healthcare expenditures.

New analysis from Frost & Sullivan (, European Market for Remote Patient Monitoring Applications, finds that the market earned revenues of $616.4 million in 2012 and estimates this to reach $831.0 million in 2018.

"Despite volatility in European economies, the market for telehealth and telecare applications is expected to grow at a consistent pace," notes Frost & Sullivan Healthcare Program Manager Sujith Eramangalath. "While Europe in general has made significant progress in the adoption and usage of RPM applications, countries like Italy and Spain, lag behind."

Such variation in adoption and penetration rates is mainly due to the different levels of public awareness about RPM technologies. Impetus from governments and healthcare organisations is also a key factor determining the levels of uptake.

"Governments have identified RPM applications as a cost-effective alternative method of healthcare delivery and are encouraging investments in them," remarks Sujith. "Private organisations and market participants are also playing their part in boosting awareness about the benefits of RPM services across Europe."

Currently, the bulk of healthcare expenditure is on in-patient care. This can be reduced to a large extent through RPM.

"RPM solutions are not only affordable but also effective in terms of providing customised care in home-based settings," adds Sujith. "As a result patients have embraced them."

However, the lack of standardised regulations and the dearth of information about funding and reimbursement deter many potential users from RPM.

"A variety of reimbursement sources add to the fragmentation and complexity of the RPM applications market," concludes Sujith. "However, the market is gradually moving towards maturity with more countries providing strong encouragement through reimbursement and also a favourable investment climate by building better awareness."

If you are interested in more information on this research, please send an email to Anna Zanchi, Corporate Communications, at

European Market for Remote Patient Monitoring Applications is part of the Connected Health Growth Partnership Service programme. Frost & Sullivan's related research services include: European Healthcare IT Professional Services Market, Data Management Systems for Patient Monitoring Markets in Europe, European Telemetry Equipment Market, and European Market for non-Invasive Blood Pressure Monitors. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents. To join our Growth Partnership, please visit

Anna Zanchi
Corporate Communications – Europe
P: +39.02.4851 6133


SOURCE Frost & Sullivan